Sigma Planning Corp - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sigma Planning Corp ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$80,000
-20.8%
73,000
+32.0%
0.00%
-33.3%
Q3 2021$101,000
+140.5%
55,310
+230.2%
0.00%
+200.0%
Q4 2020$42,000
-26.3%
16,750
-25.4%
0.00%
-50.0%
Q3 2020$57,000
-1.7%
22,450
+26.5%
0.00%
-33.3%
Q2 2020$58,000
+81.2%
17,750
+36.5%
0.00%
+50.0%
Q1 2020$32,000
-80.0%
13,000
-52.5%
0.00%
-75.0%
Q2 2019$160,00027,3800.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders